Clinical Trial Update: Serotonin-receptor Agonism in Reward Processing [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating serotonin-receptor agonism for anhedonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anhedonia

Snippet

Sponsor: University of Oxford | Conditions: Anhedonia | Phase 2 | Status: COMPLETED